Cyclacel Pharmaceuticals
CYCC
CYCC
21 hedge funds and large institutions have $1.29M invested in Cyclacel Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 4 closing their positions.
Holders
21
Holders Change
-3
Holders Change %
-12.5%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
6
Closed
4
Calls
$14K
Puts
–
Net Calls
+$14K
Net Calls Change
+$2K
Top Buyers
| 1 |
IC
1
Ikarian Capital
Dallas,
Texas
|
$11K |
| 2 |
2
Osaic Holdings
Scottsdale,
Arizona
|
$7.47K |
Top Sellers
| 1 |
1
Millennium Management
New York
|
$68K |
| 2 |
SSA
2
Schonfeld Strategic Advisors
New York
|
$420K |
| 3 |
E
3
Ergoteles
New York
|
$0 |
| 4 |
VF
4
Virtu Financial
New York
|
$0 |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$2.59K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
E
26
Ergoteles
New York
| – | -$17.3K | -7 | Closed |
|
|
CCM
27
Condor Capital Management
Martinsville,
New Jersey
| – | -$6.67K | -3 | Closed |
|
28
Simplex Trading
Chicago,
Illinois
| – | -$1K | -1 | Closed |
|